Looking for the most recent WWYD Poll? Respond to: Level of Detail for Efficacy and Safety Data in a Clinical Study Publication?
The publication team is eager to submit an abstract to a prestigious congress, but you face a dilemma. The congress explicitly states that it accepts original content only, whereas the publication team wants to develop an abstract based on data from three previously shared abstracts/publications. As the publication lead, you need to decide on the best course of action. What Would You Do?
A. Use the data from the three previous abstracts/publications as a foundation, but synthesize new insights, analyses, or perspectives. By presenting the information in a way that contributes fresh and innovative content, it should meet the congress’s originality requirement.
B. Identify a specific aspect or dimension of the data that has not been extensively explored in the previous publications. By narrowing the focus and delving deeper into this specific aspect, original findings can be generated to fulfill congress guidelines, although you may not be able to include all of the data that the publication team wants.
C. Reach out to the congress organizers to discuss the situation to help determine whether the use of some data from the previous publications is acceptable and to what extent new elements may be needed for the abstract to meet the criteria set by the congress.
D. Forgo the submission. Considering the originality requirement, a different congress that allows the submission of previously published data is more appropriate.
This poll is closed. Results will be posted in mid-July 2025.
Discover more from the Map Newsletter
Subscribe to get the latest posts sent to your email.